Please note our upcoming holiday hours. We will be CLOSED from December 25th to 28th and on January 1st. We’ll be OPEN for a half-day on December 24th and 31st, with regular hours resuming on January 2nd. “Happy Holidays”
15% off first order with code: 1storder
Competitive Prices
PNC-27 is a synthetic peptide widely studied for its innovative potential in cancer research. It is designed to target cancerous cells by interacting with the p53 protein, a key regulator of cell growth and apoptosis. By attaching to cancer cell membranes, PNC-27 selectively distinguishes between healthy and malignant cells, ensuring precise intervention in laboratory settings [1].
Spain Researchers are exploring its applications in understanding cancer cell behaviour, treatment resistance, and tumour development. While showing a significant impact in preclinical studies using animal subjects, PNC-27 is strictly for research purposes, serving as a valuable tool in advancing cancer-related scientific investigations.
Molecular Formula: C188H293N53O44S
Amino Acid Sequence: Pro-Pro-Leu-Ser-Gln-Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-Lys-Lys-Trp-Lys-Met-Arg-Arg-Asn-Gln-Phe-Trp-Val-Lys-Val-Gln-Arg-Gly-OH
Buy PNC-27 Spain Peptide Vial here – PharmaLabGlobal supplies the highest purity peptides to the research industry worldwide.
Bacteriostatic Water is required for peptide reconstitution – view the full range of peptide supplies.
PNC-27 is a synthetic peptide developed for Spain cancer research, leveraging its unique mechanism of action to target malignant cells. Central to this process is its interaction with the p53 protein, a crucial regulator of cell growth and apoptosis.
PNC-27 works by binding to the HDM-2 protein in cancer cell membranes, which is overexpressed in many cancerous cells. This binding causes the formation of pores in the membrane, disrupting the structural integrity of the cancer cell.
Unlike traditional approaches, PNC-27 demonstrates remarkable specificity by distinguishing between healthy and malignant cells. By selectively targeting cancerous cells, it induces apoptosis, a natural process of programmed cell death, without harming surrounding healthy tissues. This precision not only allows researchers to explore safer therapeutic interventions but also deepens the understanding of cancer cell behaviour [2].
Although still in the research phase, PNC-27 offers valuable insights into potential targeted treatments, paving the way for innovation in cancer studies.
Buy PNC-27 Spain Nasal Spray for research use from Pharma Lab Global Website – a trusted supplier of peptides worldwide. Peptide Nasal Sprays are available in 15 ml or 30 ml ready to use bottles.
Targets Cancerous Cells
PNC-27 specifically targets cancerous cells through a well-defined mechanism that revolves around its interaction with the HDM-2 protein. This protein is frequently overexpressed on the membranes of malignant cells, making it a strategic target. PNC-27 binds to HDM-2, triggering a sequence of events that disrupt the normal functioning of the cancer cell [1].
Once bound to HDM-2, PNC-27 induces the formation of pores in the cancer cell membrane. This pore formation compromises the membrane’s structural integrity, leading to cellular instability. Such targeted damage sets the stage for the cancer cell lines demise. Unlike traditional methods that may harm healthy cells, PNC-27 showcases remarkable specificity, selectively recognizing and acting on cancerous cells while leaving surrounding healthy tissue unharmed.
The disruption of the cancer cell membrane ultimately induces apoptosis, or programmed cancer cell death. This natural process ensures that the malignant cells are eliminated efficiently. By focusing on these targeted interactions, PNC-27 provides valuable insights for researchers exploring innovative and safer therapeutic approaches for treatment options to combat cancer [3].
Distinguishes Between Healthy & Malignant Cells
Further evidence suggests that PNC-27 distinguishes between healthy and malignant cells by targeting the HDM-2 protein, a feature that sets it apart in cancer research. The HDM-2 protein plays a role in regulating the p53 tumor suppressor pathway and is often overexpressed on the membranes of cancer cells. This overexpression provides PNC-27 with a unique marker to identify and bind specifically to malignant cells [4].
Healthy cells, in contrast, typically express HDM-2 at normal levels, which prevents PNC-27 from interacting with them in a significant or harmful way. This specificity allows PNC-27 to recognize and selectively target only cancerous cells. Once bound to the HDM-2 protein on malignant cells, PNC-27 induces the formation of pores in the cancer cell membrane, leading to apoptosis.
This precise targeting mechanism ensures that healthy tissues remain unaffected, making PNC-27 a powerful tool in research focused on safer, targeted cancer therapies and treatments.
Important Role in Cancer Research
Clinical trials have shown that PNC-27 holds great promise for future cancer research. Its unique mechanism of action, which involves targeting the HDM-2 protein overexpressed on various cancer cell lines, makes it a valuable tool for exploring innovative cancer therapies. By selectively inducing apoptosis in malignant cells while sparing healthy tissues, PNC-27 offers a targeted approach that could minimize side effects compared to traditional treatments [5].
Researchers could further investigate its potential applications in various cancer types, its efficacy in combination with other therapies, and its long-term safety profile. Additionally, understanding its interaction with the p53 pathway could provide deeper insights into tumour biology and resistance mechanisms.
While still in the research phase, PNC-27’s specificity and effectiveness make it a novel therapeutic approach for advancing cancer treatment strategies, paving the way for more precise and less invasive therapeutic options
Is PNC-27 currently used as a cancer treatment?
PNC-27 is not approved or recommended for the treatment of cancer for human use. The FDA has warned against its use, citing contamination risks with harmful bacteria residues that could cause serious infections with the use of this product. PNC-27 has not been evaluated for safety or efficacy, and its various forms, such as nebulized or intravenous solutions, pose significant health risks. The terms of use of this product are for research use only – it is important to consult with a healthcare professional regarding any treatment and adhere to Spain applicable laws.
PharmaLabGlobal is one of the best locations to purchase high purity PNC 27 for laboratory purposes.
[1] Krzesaj P, Adler V, Feinman RD, Miller A, Silberstein M, Yazdi E, Pincus MR. Anti-Cancer Peptide PNC-27 Kills Cancer Cells by Unique Interactions with Plasma Membrane-Bound hdm-2 and with Mitochondrial Membranes Causing Mitochondrial Disruption. Ann Clin Lab Sci. 2024 Mar;54(2):137-148.
[2] Pincus MR, Silberstein M, Zohar N, Sarafraz-Yazdi E, Bowne WB. Poptosis or Peptide-Induced Transmembrane Pore Formation: A Novel Way to Kill Cancer Cells without Affecting Normal Cells. Biomedicines. 2024 May 22;12(6):1144.
[3] Sookraj KA, Bowne WB, Adler V, Sarafraz-Yazdi E, Michl J, Pincus MR. The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide. Cancer Chemother Pharmacol. 2010 Jul;66(2):325-31.
[4] Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell. 2003 Jun;3(6):577-87.
[5] Sarafraz-Yazdi E, Bowne WB, Adler V, Sookraj KA, Wu V, Shteyler V, Patel H, Oxbury W, Brandt-Rauf P, Zenilman ME, Michl J, Pincus MR. Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes. Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):1918-23.
PNC-27 Peptide and Its Potential Role in Tumour Growth Suppression
Uncover the potential of PNC-27 peptide in advancing tumour growth suppression research. This blog dives into the unique mechanism of PNC-27, which targets the HDM-2 protein overexpressed on cancerous cell membranes. By inducing necrosis through membrane disruption, PNC-27 selectively destroys tumour cells while sparing healthy tissue. The post also explores the peptide’s implications for precise, targeted cancer therapies, offering valuable insights into safer and more effective approaches to combating tumours. Explore how this innovative peptide is shaping the future of cancer research.
Peptides for Prostate Health
Explore the potential of peptides in enhancing prostate health. This blog highlights peptides such as GHRP-6, CJC-1295, Epithalon, and BPC-157, which show promise in reducing inflammation, promoting tissue repair, and targeting mechanisms linked to prostate conditions like BPH and prostate cancer. Learn how these research peptides could inform new therapeutic and preventive strategies for prostate health.
Is PNC-27 a Breakthrough Peptide in Breast Cancer Research?
Discover the promise of PNC-27 in breast cancer research. This blog examines how PNC-27 selectively targets the HDM-2 protein, which is commonly overexpressed in breast cancer cells. By binding to HDM-2, this peptide disrupts cancer cell membranes, leading to targeted cell death while sparing healthy tissues. The piece also highlights advancements in peptide delivery methods and compares PNC-27’s precision with traditional treatments like chemotherapy. Explore how this innovative peptide is reshaping our understanding of breast cancer biology and paving the way for future breakthroughs.
Peptides are manufactured to a purity standard of 99% (complex peptides are 98% pure or higher)
At Pharma Lab Global we supply premium peptides to the research industry worldwide.
Our mission and priority are to ensure that clients receive a superior customer experience.
At Pharma Lab Global we aim to supply the highest purity research peptides at affordable prices.
ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY
DISCLAIMER: All products sold by Pharma Lab Global are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals.
